Tumor Embolization Market, Global Outlook and Forecast 2022-2028

January 2022 | 69 pages | ID: T813B0642D6CEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Tumor Embolization in Global, including the following market information:

Global Tumor Embolization Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Tumor Embolization market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Trans-Arterial Embolization (TAE) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tumor Embolization include Boston Scientific Corporation, Varian Medical Systems, Inc., Nordion (Sotera Health) and Sirtex Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tumor Embolization companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tumor Embolization Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Tumor Embolization Market Segment Percentages, by Type, 2021 (%)

• Trans-Arterial Embolization (TAE)
• Drug-Eluting Bead Chemoembolization (DEB-TACE)
• Radioembolization (RE)
• Others

Global Tumor Embolization Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Tumor Embolization Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Global Tumor Embolization Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Tumor Embolization Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Tumor Embolization revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Tumor Embolization revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Boston Scientific Corporation
• Varian Medical Systems, Inc.
• Nordion (Sotera Health)
• Sirtex Medical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Tumor Embolization Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Tumor Embolization Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TUMOR EMBOLIZATION OVERALL MARKET SIZE

2.1 Global Tumor Embolization Market Size: 2021 VS 2028
2.2 Global Tumor Embolization Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Tumor Embolization Players in Global Market
3.2 Top Global Tumor Embolization Companies Ranked by Revenue
3.3 Global Tumor Embolization Revenue by Companies
3.4 Top 3 and Top 5 Tumor Embolization Companies in Global Market, by Revenue in 2021
3.5 Global Companies Tumor Embolization Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tumor Embolization Players in Global Market
  3.6.1 List of Global Tier 1 Tumor Embolization Companies
  3.6.2 List of Global Tier 2 and Tier 3 Tumor Embolization Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Tumor Embolization Market Size Markets, 2021 & 2028
  4.1.2 Trans-Arterial Embolization (TAE)
  4.1.3 Drug-Eluting Bead Chemoembolization (DEB-TACE)
  4.1.4 Radioembolization (RE)
  4.1.5 Others
4.2 By Type - Global Tumor Embolization Revenue & Forecasts
  4.2.1 By Type - Global Tumor Embolization Revenue, 2017-2022
  4.2.2 By Type - Global Tumor Embolization Revenue, 2023-2028
  4.2.3 By Type - Global Tumor Embolization Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Tumor Embolization Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Centers
  5.1.4 Specialty Clinics
  5.1.5 Others
5.2 By Application - Global Tumor Embolization Revenue & Forecasts
  5.2.1 By Application - Global Tumor Embolization Revenue, 2017-2022
  5.2.2 By Application - Global Tumor Embolization Revenue, 2023-2028
  5.2.3 By Application - Global Tumor Embolization Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Tumor Embolization Market Size, 2021 & 2028
6.2 By Region - Global Tumor Embolization Revenue & Forecasts
  6.2.1 By Region - Global Tumor Embolization Revenue, 2017-2022
  6.2.2 By Region - Global Tumor Embolization Revenue, 2023-2028
  6.2.3 By Region - Global Tumor Embolization Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Tumor Embolization Revenue, 2017-2028
  6.3.2 US Tumor Embolization Market Size, 2017-2028
  6.3.3 Canada Tumor Embolization Market Size, 2017-2028
  6.3.4 Mexico Tumor Embolization Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Tumor Embolization Revenue, 2017-2028
  6.4.2 Germany Tumor Embolization Market Size, 2017-2028
  6.4.3 France Tumor Embolization Market Size, 2017-2028
  6.4.4 U.K. Tumor Embolization Market Size, 2017-2028
  6.4.5 Italy Tumor Embolization Market Size, 2017-2028
  6.4.6 Russia Tumor Embolization Market Size, 2017-2028
  6.4.7 Nordic Countries Tumor Embolization Market Size, 2017-2028
  6.4.8 Benelux Tumor Embolization Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Tumor Embolization Revenue, 2017-2028
  6.5.2 China Tumor Embolization Market Size, 2017-2028
  6.5.3 Japan Tumor Embolization Market Size, 2017-2028
  6.5.4 South Korea Tumor Embolization Market Size, 2017-2028
  6.5.5 Southeast Asia Tumor Embolization Market Size, 2017-2028
  6.5.6 India Tumor Embolization Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Tumor Embolization Revenue, 2017-2028
  6.6.2 Brazil Tumor Embolization Market Size, 2017-2028
  6.6.3 Argentina Tumor Embolization Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Tumor Embolization Revenue, 2017-2028
  6.7.2 Turkey Tumor Embolization Market Size, 2017-2028
  6.7.3 Israel Tumor Embolization Market Size, 2017-2028
  6.7.4 Saudi Arabia Tumor Embolization Market Size, 2017-2028
  6.7.5 UAE Tumor Embolization Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Boston Scientific Corporation
  7.1.1 Boston Scientific Corporation Corporate Summary
  7.1.2 Boston Scientific Corporation Business Overview
  7.1.3 Boston Scientific Corporation Tumor Embolization Major Product Offerings
  7.1.4 Boston Scientific Corporation Tumor Embolization Revenue in Global Market (2017-2022)
  7.1.5 Boston Scientific Corporation Key News
7.2 Varian Medical Systems, Inc.
  7.2.1 Varian Medical Systems, Inc. Corporate Summary
  7.2.2 Varian Medical Systems, Inc. Business Overview
  7.2.3 Varian Medical Systems, Inc. Tumor Embolization Major Product Offerings
  7.2.4 Varian Medical Systems, Inc. Tumor Embolization Revenue in Global Market (2017-2022)
  7.2.5 Varian Medical Systems, Inc. Key News
7.3 Nordion (Sotera Health)
  7.3.1 Nordion (Sotera Health) Corporate Summary
  7.3.2 Nordion (Sotera Health) Business Overview
  7.3.3 Nordion (Sotera Health) Tumor Embolization Major Product Offerings
  7.3.4 Nordion (Sotera Health) Tumor Embolization Revenue in Global Market (2017-2022)
  7.3.5 Nordion (Sotera Health) Key News
7.4 Sirtex Medical
  7.4.1 Sirtex Medical Corporate Summary
  7.4.2 Sirtex Medical Business Overview
  7.4.3 Sirtex Medical Tumor Embolization Major Product Offerings
  7.4.4 Sirtex Medical Tumor Embolization Revenue in Global Market (2017-2022)
  7.4.5 Sirtex Medical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Tumor Embolization Market Opportunities & Trends in Global Market
Table 2. Tumor Embolization Market Drivers in Global Market
Table 3. Tumor Embolization Market Restraints in Global Market
Table 4. Key Players of Tumor Embolization in Global Market
Table 5. Top Tumor Embolization Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Tumor Embolization Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Tumor Embolization Revenue Share by Companies, 2017-2022
Table 8. Global Companies Tumor Embolization Product Type
Table 9. List of Global Tier 1 Tumor Embolization Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tumor Embolization Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Tumor Embolization Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Tumor Embolization Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Tumor Embolization Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Tumor Embolization Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Tumor Embolization Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Tumor Embolization Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Tumor Embolization Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Tumor Embolization Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Tumor Embolization Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Tumor Embolization Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Tumor Embolization Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Tumor Embolization Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Tumor Embolization Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Tumor Embolization Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Tumor Embolization Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Tumor Embolization Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Tumor Embolization Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Tumor Embolization Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Tumor Embolization Revenue, (US$, Mn), 2023-2028
Table 30. Boston Scientific Corporation Corporate Summary
Table 31. Boston Scientific Corporation Tumor Embolization Product Offerings
Table 32. Boston Scientific Corporation Tumor Embolization Revenue (US$, Mn), (2017-2022)
Table 33. Varian Medical Systems, Inc. Corporate Summary
Table 34. Varian Medical Systems, Inc. Tumor Embolization Product Offerings
Table 35. Varian Medical Systems, Inc. Tumor Embolization Revenue (US$, Mn), (2017-2022)
Table 36. Nordion (Sotera Health) Corporate Summary
Table 37. Nordion (Sotera Health) Tumor Embolization Product Offerings
Table 38. Nordion (Sotera Health) Tumor Embolization Revenue (US$, Mn), (2017-2022)
Table 39. Sirtex Medical Corporate Summary
Table 40. Sirtex Medical Tumor Embolization Product Offerings
Table 41. Sirtex Medical Tumor Embolization Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Tumor Embolization Segment by Type in 2021
Figure 2. Tumor Embolization Segment by Application in 2021
Figure 3. Global Tumor Embolization Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Tumor Embolization Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tumor Embolization Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tumor Embolization Revenue in 2021
Figure 8. By Type - Global Tumor Embolization Revenue Market Share, 2017-2028
Figure 9. By Application - Global Tumor Embolization Revenue Market Share, 2017-2028
Figure 10. By Region - Global Tumor Embolization Revenue Market Share, 2017-2028
Figure 11. By Country - North America Tumor Embolization Revenue Market Share, 2017-2028
Figure 12. US Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Tumor Embolization Revenue Market Share, 2017-2028
Figure 16. Germany Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 17. France Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Tumor Embolization Revenue Market Share, 2017-2028
Figure 24. China Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 28. India Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Tumor Embolization Revenue Market Share, 2017-2028
Figure 30. Brazil Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Tumor Embolization Revenue Market Share, 2017-2028
Figure 33. Turkey Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Tumor Embolization Revenue, (US$, Mn), 2017-2028
Figure 37. Boston Scientific Corporation Tumor Embolization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Varian Medical Systems, Inc. Tumor Embolization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Nordion (Sotera Health) Tumor Embolization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sirtex Medical Tumor Embolization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)